Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes.

about

Mathematical Models of HIV Latency.Effects of spatiotemporal HSV-2 lesion dynamics and antiviral treatment on the risk of HIV-1 acquisition.A Fixed Spatial Structure of CD8 T Cells in Tissue during Chronic HSV-2 Infection Insight into treatment of HIV infection from viral dynamics models

P2860

Q47574091-965CCEDB-B720-42F0-B0EC-17CEB6D567EA Q52561266-22678C67-27E8-48CD-82B8-E837B8163A7F Q57269664-A69430FF-F682-43D0-82F7-E8B005203C84 Q58788145-366079D1-C796-4658-A0DB-7EF19B6F63C7

P2860

Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes.

Item

http://www.wikidata.org/entity/Q27324453

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Mathematical modeling of herpe ...... elivir predicts trial outcomes

@nl

Mathematical modeling of herpe ...... livir predicts trial outcomes.

@ast

Mathematical modeling of herpe ...... livir predicts trial outcomes.

@en

type

Item

label

Mathematical modeling of herpe ...... elivir predicts trial outcomes

@nl

Mathematical modeling of herpe ...... livir predicts trial outcomes.

@ast

Mathematical modeling of herpe ...... livir predicts trial outcomes.

@en

prefLabel

Mathematical modeling of herpe ...... elivir predicts trial outcomes

@nl

Mathematical modeling of herpe ...... livir predicts trial outcomes.

@ast

Mathematical modeling of herpe ...... livir predicts trial outcomes.

@en

P1476

Mathematical modeling of herpe ...... livir predicts trial outcomes.

@en

P2093

Alexander Birkmann

http://www.w3.org/2001/XMLSchema#string

Amalia Magaret

http://www.w3.org/2001/XMLSchema#string

Burkhard Timmler

http://www.w3.org/2001/XMLSchema#string

Christopher M Rubino

http://www.w3.org/2001/XMLSchema#string

David A Swan

http://www.w3.org/2001/XMLSchema#string

Helga Ruebsamen-Schaeff

http://www.w3.org/2001/XMLSchema#string

Holger Zimmermann

http://www.w3.org/2001/XMLSchema#string

Joachim Ossig

http://www.w3.org/2001/XMLSchema#string

Joshua T Schiffer

http://www.w3.org/2001/XMLSchema#string

Murad R Melhem

http://www.w3.org/2001/XMLSchema#string

P2860

Virologic characteristics of subclinical and symptomatic genital herpes infections

Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum

Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model.

Herpes simplex virus-2 genital tract shedding is not predictable over months or years in infected persons.

Rapidly cleared episodes of oral and anogenital herpes simplex virus shedding in HIV-infected adults

New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease.

The kinetics of mucosal herpes simplex virus-2 infection in humans: evidence for rapid viral-host interactions.

P304

324ra15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.AAD6654

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

324

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anna Wald

Lawrence Corey

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26843190

http://www.w3.org/2001/XMLSchema#string

P921

virology

P932

4880060

http://www.w3.org/2001/XMLSchema#string

Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes.

about

P2860

P2860

Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932